Work

Cardiovascular (CV) safety of indacaterol/glycopyrronium (IND/GLY) compared with salmeterol/fluticasone combination (SFC) in moderate-to-very severe COPD patients with prior exacerbations: The FLAME study

Year: 2016

Type: conference-abstract

Source: European Respiratory Journal

DOI: 10.1183/13993003.congress-2016.pa311

Authors: Nicolas Roche, Petter Olsson, Jørgen Vestbo, Angel FowlerTaylor, Tim Ayers, Chau Thach, Karyn Clerkin, Robert Fogel, Francesco Patalano, Donald Banerji

Institutions: Assistance Publique – Hôpitaux de Paris, Université Paris Descartes, Novartis (Switzerland), University of Manchester, Novartis (United States), Novartis (Ireland)

Language: English

Topic: Chronic Obstructive Pulmonary Disease (COPD) Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2549400454

Cites:

Cited by: 1

Related to: 10